APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastric Motility Disorder Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gastric Motility Disorder Drug Market Analysis and Forecast 2026-2032

19 December 2025190 pages

Choose your research edition.

Industry ResearchGastric Motility Disorder Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastric Motility Disorder Drug Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Gastric Motility Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastric Motility Disorder Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastric Motility Disorder Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Gastric Motility Disorder Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gastric Motility Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gastric Motility Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gastric Motility Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gastric Motility Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gastric Motility Disorder Drug include Theravance, Inc., Targacept, Inc., Helsinn Healthcare S.A., Concert Pharmaceuticals, Inc. and ChironWells GmbH, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gastric Motility Disorder Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gastric Motility Disorder Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Gastric Motility Disorder Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastric Motility Disorder Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gastric Motility Disorder Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gastric Motility Disorder Drug sales, projected growth trends, production technology, application and end-user industry.

Gastric Motility Disorder Drug Segment by Company

Theravance, Inc.

Targacept, Inc.

Helsinn Healthcare S.A.

Concert Pharmaceuticals, Inc.

ChironWells GmbH

Gastric Motility Disorder Drug Segment by Type

Ipamorelin

Velusetrag

TD-8954

Others

Gastric Motility Disorder Drug Segment by Application

Hospital

Clinic

Home Use

Gastric Motility Disorder Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastric Motility Disorder Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastric Motility Disorder Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastric Motility Disorder Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gastric Motility Disorder Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gastric Motility Disorder Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastric Motility Disorder Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gastric Motility Disorder Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ipamorelin Major Manufacturers Table 3. Velusetrag Major Manufacturers Table 4. TD-8954 Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Gastric Motility Disorder Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Home Use Major Manufacturers Table 10. Gastric Motility Disorder Drug Industry Trends Table 11. Gastric Motility Disorder Drug Industry Drivers Table 12. Gastric Motility Disorder Drug Industry Opportunities and Challenges Table 13. Gastric Motility Disorder Drug Industry Restraints Table 14. Global Gastric Motility Disorder Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Gastric Motility Disorder Drug Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Gastric Motility Disorder Drug Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Gastric Motility Disorder Drug Revenue Market Share by Region (2021-2026) Table 18. Global Gastric Motility Disorder Drug Revenue Market Share by Region (2027-2032) Table 19. Global Gastric Motility Disorder Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Gastric Motility Disorder Drug Sales by Region (2021-2026) & (K Units) Table 21. Global Gastric Motility Disorder Drug Sales by Region (2027-2032) & (K Units) Table 22. Global Gastric Motility Disorder Drug Sales Market Share by Region (2021-2026) Table 23. Global Gastric Motility Disorder Drug Sales Market Share by Region (2027-2032) Table 24. Global Gastric Motility Disorder Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Gastric Motility Disorder Drug Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Gastric Motility Disorder Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Gastric Motility Disorder Drug Sales Market Share by Manufacturers (2021-2026) Table 28. Global Gastric Motility Disorder Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Gastric Motility Disorder Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Gastric Motility Disorder Drug Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Gastric Motility Disorder Drug Manufacturers, Product Type & Application Table 32. Global Gastric Motility Disorder Drug Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Gastric Motility Disorder Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Gastric Motility Disorder Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Gastric Motility Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Gastric Motility Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Gastric Motility Disorder Drug Revenue Market Share by Type (2021-2026) Table 39. Global Gastric Motility Disorder Drug Revenue Market Share by Type (2027-2032) Table 40. Global Gastric Motility Disorder Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Gastric Motility Disorder Drug Sales by Type (2021-2026) & (K Units) Table 42. Global Gastric Motility Disorder Drug Sales by Type (2027-2032) & (K Units) Table 43. Global Gastric Motility Disorder Drug Sales Market Share by Type (2021-2026) Table 44. Global Gastric Motility Disorder Drug Sales Market Share by Type (2027-2032) Table 45. Global Gastric Motility Disorder Drug Price by Type (2021-2026) & (US$/Unit) Table 46. Global Gastric Motility Disorder Drug Price by Type (2027-2032) & (US$/Unit) Table 47. Global Gastric Motility Disorder Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Gastric Motility Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Gastric Motility Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Gastric Motility Disorder Drug Revenue Market Share by Application (2021-2026) Table 51. Global Gastric Motility Disorder Drug Revenue Market Share by Application (2027-2032) Table 52. Global Gastric Motility Disorder Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Gastric Motility Disorder Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Gastric Motility Disorder Drug Sales by Application (2027-2032) & (K Units) Table 55. Global Gastric Motility Disorder Drug Sales Market Share by Application (2021-2026) Table 56. Global Gastric Motility Disorder Drug Sales Market Share by Application (2027-2032) Table 57. Global Gastric Motility Disorder Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Gastric Motility Disorder Drug Price by Application (2027-2032) & (US$/Unit) Table 59. Theravance, Inc. Company Information Table 60. Theravance, Inc. Business Overview Table 61. Theravance, Inc. Gastric Motility Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Theravance, Inc. Gastric Motility Disorder Drug Product Portfolio Table 63. Theravance, Inc. Recent Development Table 64. Targacept, Inc. Company Information Table 65. Targacept, Inc. Business Overview Table 66. Targacept, Inc. Gastric Motility Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Targacept, Inc. Gastric Motility Disorder Drug Product Portfolio Table 68. Targacept, Inc. Recent Development Table 69. Helsinn Healthcare S.A. Company Information Table 70. Helsinn Healthcare S.A. Business Overview Table 71. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Product Portfolio Table 73. Helsinn Healthcare S.A. Recent Development Table 74. Concert Pharmaceuticals, Inc. Company Information Table 75. Concert Pharmaceuticals, Inc. Business Overview Table 76. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Product Portfolio Table 78. Concert Pharmaceuticals, Inc. Recent Development Table 79. ChironWells GmbH Company Information Table 80. ChironWells GmbH Business Overview Table 81. ChironWells GmbH Gastric Motility Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. ChironWells GmbH Gastric Motility Disorder Drug Product Portfolio Table 83. ChironWells GmbH Recent Development Table 84. North America Gastric Motility Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 85. North America Gastric Motility Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 86. North America Gastric Motility Disorder Drug Sales by Type (2021-2026) & (K Units) Table 87. North America Gastric Motility Disorder Drug Sales by Type (2027-2032) & (K Units) Table 88. North America Gastric Motility Disorder Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 89. North America Gastric Motility Disorder Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 90. North America Gastric Motility Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 91. North America Gastric Motility Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 92. North America Gastric Motility Disorder Drug Sales by Application (2021-2026) & (K Units) Table 93. North America Gastric Motility Disorder Drug Sales by Application (2027-2032) & (K Units) Table 94. North America Gastric Motility Disorder Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 95. North America Gastric Motility Disorder Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 96. North America Gastric Motility Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Gastric Motility Disorder Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 98. North America Gastric Motility Disorder Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 99. North America Gastric Motility Disorder Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 100. North America Gastric Motility Disorder Drug Sales by Country (2021-2026) & (K Units) Table 101. North America Gastric Motility Disorder Drug Sales by Country (2027-2032) & (K Units) Table 102. North America Gastric Motility Disorder Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 103. North America Gastric Motility Disorder Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 104. United States Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 105. Canada Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 106. Europe Gastric Motility Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 107. Europe Gastric Motility Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 108. Europe Gastric Motility Disorder Drug Sales by Type (2021-2026) & (K Units) Table 109. Europe Gastric Motility Disorder Drug Sales by Type (2027-2032) & (K Units) Table 110. Europe Gastric Motility Disorder Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 111. Europe Gastric Motility Disorder Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 112. Europe Gastric Motility Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 113. Europe Gastric Motility Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 114. Europe Gastric Motility Disorder Drug Sales by Application (2021-2026) & (K Units) Table 115. Europe Gastric Motility Disorder Drug Sales by Application (2027-2032) & (K Units) Table 116. Europe Gastric Motility Disorder Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 117. Europe Gastric Motility Disorder Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 118. Europe Gastric Motility Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Gastric Motility Disorder Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 120. Europe Gastric Motility Disorder Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 121. Europe Gastric Motility Disorder Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 122. Europe Gastric Motility Disorder Drug Sales by Country (2021-2026) & (K Units) Table 123. Europe Gastric Motility Disorder Drug Sales by Country (2027-2032) & (K Units) Table 124. Europe Gastric Motility Disorder Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 125. Europe Gastric Motility Disorder Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 126. Germany Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 127. France Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 128. U.K. Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 129. Italy Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 130. Netherlands Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 131. China Gastric Motility Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 132. China Gastric Motility Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 133. China Gastric Motility Disorder Drug Sales by Type (2021-2026) & (K Units) Table 134. China Gastric Motility Disorder Drug Sales by Type (2027-2032) & (K Units) Table 135. China Gastric Motility Disorder Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 136. China Gastric Motility Disorder Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 137. China Gastric Motility Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 138. China Gastric Motility Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 139. China Gastric Motility Disorder Drug Sales by Application (2021-2026) & (K Units) Table 140. China Gastric Motility Disorder Drug Sales by Application (2027-2032) & (K Units) Table 141. China Gastric Motility Disorder Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 142. China Gastric Motility Disorder Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Asia Gastric Motility Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia Gastric Motility Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia Gastric Motility Disorder Drug Sales by Type (2021-2026) & (K Units) Table 146. Asia Gastric Motility Disorder Drug Sales by Type (2027-2032) & (K Units) Table 147. Asia Gastric Motility Disorder Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 148. Asia Gastric Motility Disorder Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 149. Asia Gastric Motility Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 150. Asia Gastric Motility Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Gastric Motility Disorder Drug Sales by Application (2021-2026) & (K Units) Table 152. Asia Gastric Motility Disorder Drug Sales by Application (2027-2032) & (K Units) Table 153. Asia Gastric Motility Disorder Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 154. Asia Gastric Motility Disorder Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 155. Asia Gastric Motility Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Asia Gastric Motility Disorder Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. Asia Gastric Motility Disorder Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. Asia Gastric Motility Disorder Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 159. Asia Gastric Motility Disorder Drug Sales by Country (2021-2026) & (K Units) Table 160. Asia Gastric Motility Disorder Drug Sales by Country (2027-2032) & (K Units) Table 161. Asia Gastric Motility Disorder Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 162. Asia Gastric Motility Disorder Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 163. Japan Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 164. South Korea Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 165. India Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 166. Australia Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 167. China Taiwan Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 168. Southeast Asia Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 169. SAMEA Gastric Motility Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 170. SAMEA Gastric Motility Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 171. SAMEA Gastric Motility Disorder Drug Sales by Type (2021-2026) & (K Units) Table 172. SAMEA Gastric Motility Disorder Drug Sales by Type (2027-2032) & (K Units) Table 173. SAMEA Gastric Motility Disorder Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 174. SAMEA Gastric Motility Disorder Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 175. SAMEA Gastric Motility Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 176. SAMEA Gastric Motility Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 177. SAMEA Gastric Motility Disorder Drug Sales by Application (2021-2026) & (K Units) Table 178. SAMEA Gastric Motility Disorder Drug Sales by Application (2027-2032) & (K Units) Table 179. SAMEA Gastric Motility Disorder Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 180. SAMEA Gastric Motility Disorder Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 181. SAMEA Gastric Motility Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. SAMEA Gastric Motility Disorder Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. SAMEA Gastric Motility Disorder Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. SAMEA Gastric Motility Disorder Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 185. SAMEA Gastric Motility Disorder Drug Sales by Country (2021-2026) & (K Units) Table 186. SAMEA Gastric Motility Disorder Drug Sales by Country (2027-2032) & (K Units) Table 187. SAMEA Gastric Motility Disorder Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 188. SAMEA Gastric Motility Disorder Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 189. Brazil Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 190. Argentina Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 191. Chile Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 192. Colombia Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 193. Peru Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 194. Saudi Arabia Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 195. Israel Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 196. UAE Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 197. Turkey Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 198. Iran Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 199. Egypt Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Table 200. Key Raw Materials Table 201. Raw Materials Key Suppliers Table 202. Gastric Motility Disorder Drug Distributors List Table 203. Gastric Motility Disorder Drug Customers List Table 204. Research Programs/Design for This Report Table 205. Authors List of This Report Table 206. Secondary Sources Table 207. Primary Sources List of Figures Figure 1. Gastric Motility Disorder Drug Image Figure 2. Global Gastric Motility Disorder Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastric Motility Disorder Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ipamorelin Image Figure 5. Velusetrag Image Figure 6. TD-8954 Image Figure 7. Others Image Figure 8. Global Gastric Motility Disorder Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Gastric Motility Disorder Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Home Use Image Figure 13. Global Gastric Motility Disorder Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Gastric Motility Disorder Drug Revenue (2021-2032) & (US$ Million) Figure 15. Global Gastric Motility Disorder Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Gastric Motility Disorder Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Gastric Motility Disorder Drug Revenue Market Share by Region (2021-2032) Figure 18. Global Gastric Motility Disorder Drug Sales (2021-2032) & (K Units) Figure 19. Global Gastric Motility Disorder Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Gastric Motility Disorder Drug Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Gastric Motility Disorder Drug Sales YoY (2021-2032) & (K Units) Figure 22. Europe Gastric Motility Disorder Drug Sales YoY (2021-2032) & (K Units) Figure 23. China Gastric Motility Disorder Drug Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Gastric Motility Disorder Drug Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Gastric Motility Disorder Drug Sales YoY (2021-2032) & (K Units) Figure 26. Global Gastric Motility Disorder Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Gastric Motility Disorder Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Gastric Motility Disorder Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Gastric Motility Disorder Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Gastric Motility Disorder Drug Revenue Market Share by Type (2021-2032) Figure 32. Global Gastric Motility Disorder Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Gastric Motility Disorder Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Gastric Motility Disorder Drug Sales Market Share by Type (2021-2032) Figure 35. Global Gastric Motility Disorder Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Gastric Motility Disorder Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Gastric Motility Disorder Drug Revenue Market Share by Application (2021-2032) Figure 38. Global Gastric Motility Disorder Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Gastric Motility Disorder Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Gastric Motility Disorder Drug Sales Market Share by Application (2021-2032) Figure 41. North America Gastric Motility Disorder Drug Revenue Share by Type (2021-2032) Figure 42. North America Gastric Motility Disorder Drug Sales Share by Type (2021-2032) Figure 43. North America Gastric Motility Disorder Drug Revenue Share by Application (2021-2032) Figure 44. North America Gastric Motility Disorder Drug Sales Share by Application (2021-2032) Figure 45. North America Gastric Motility Disorder Drug Revenue Share by Country (2021-2032) Figure 46. North America Gastric Motility Disorder Drug Sales Share by Country (2021-2032) Figure 47. Europe Gastric Motility Disorder Drug Revenue Share by Type (2021-2032) Figure 48. Europe Gastric Motility Disorder Drug Sales Share by Type (2021-2032) Figure 49. Europe Gastric Motility Disorder Drug Revenue Share by Application (2021-2032) Figure 50. Europe Gastric Motility Disorder Drug Sales Share by Application (2021-2032) Figure 51. Europe Gastric Motility Disorder Drug Revenue Share by Country (2021-2032) Figure 52. Europe Gastric Motility Disorder Drug Sales Share by Country (2021-2032) Figure 53. China Gastric Motility Disorder Drug Revenue Share by Type (2021-2032) Figure 54. China Gastric Motility Disorder Drug Sales Share by Type (2021-2032) Figure 55. China Gastric Motility Disorder Drug Revenue Share by Application (2021-2032) Figure 56. China Gastric Motility Disorder Drug Sales Share by Application (2021-2032) Figure 57. Asia Gastric Motility Disorder Drug Revenue Share by Type (2021-2032) Figure 58. Asia Gastric Motility Disorder Drug Sales Share by Type (2021-2032) Figure 59. Asia Gastric Motility Disorder Drug Revenue Share by Application (2021-2032) Figure 60. Asia Gastric Motility Disorder Drug Sales Share by Application (2021-2032) Figure 61. Asia Gastric Motility Disorder Drug Revenue Share by Country (2021-2032) Figure 62. Asia Gastric Motility Disorder Drug Sales Share by Country (2021-2032) Figure 63. SAMEA Gastric Motility Disorder Drug Revenue Share by Type (2021-2032) Figure 64. SAMEA Gastric Motility Disorder Drug Sales Share by Type (2021-2032) Figure 65. SAMEA Gastric Motility Disorder Drug Revenue Share by Application (2021-2032) Figure 66. SAMEA Gastric Motility Disorder Drug Sales Share by Application (2021-2032) Figure 67. SAMEA Gastric Motility Disorder Drug Revenue Share by Country (2021-2032) Figure 68. SAMEA Gastric Motility Disorder Drug Sales Share by Country (2021-2032) Figure 69. Gastric Motility Disorder Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Gastric Motility Disorder Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Ipamorelin
  • Velusetrag
  • TD-8954
  • Others
Applications
  • Hospital
  • Clinic
  • Home Use
Companies covered
  • Theravance, Inc.
  • Targacept, Inc.
  • Helsinn Healthcare S.A.
  • Concert Pharmaceuticals, Inc.
  • ChironWells GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gastric Motility Disorder Drug Market by Type
  3. 1.2.1 Global Gastric Motility Disorder Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ipamorelin
  5. 1.2.3 Velusetrag
  6. 1.2.4 TD-8954
  7. 1.2.5 Others
  8. 1.3 Gastric Motility Disorder Drug Market by Application
  9. 1.3.1 Global Gastric Motility Disorder Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Home Use
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Gastric Motility Disorder Drug Market Dynamics
  1. 2.1 Gastric Motility Disorder Drug Industry Trends
  2. 2.2 Gastric Motility Disorder Drug Industry Drivers
  3. 2.3 Gastric Motility Disorder Drug Industry Opportunities and Challenges
  4. 2.4 Gastric Motility Disorder Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gastric Motility Disorder Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gastric Motility Disorder Drug Revenue by Region
  3. 3.2.1 Global Gastric Motility Disorder Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gastric Motility Disorder Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Gastric Motility Disorder Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Gastric Motility Disorder Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gastric Motility Disorder Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gastric Motility Disorder Drug Sales by Region
  9. 3.4.1 Global Gastric Motility Disorder Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gastric Motility Disorder Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Gastric Motility Disorder Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Gastric Motility Disorder Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gastric Motility Disorder Drug Revenue by Manufacturers
  2. 4.1.1 Global Gastric Motility Disorder Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gastric Motility Disorder Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gastric Motility Disorder Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gastric Motility Disorder Drug Sales by Manufacturers
  6. 4.2.1 Global Gastric Motility Disorder Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gastric Motility Disorder Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gastric Motility Disorder Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gastric Motility Disorder Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gastric Motility Disorder Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gastric Motility Disorder Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gastric Motility Disorder Drug Manufacturers, Product Type & Application
  13. 4.7 Global Gastric Motility Disorder Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gastric Motility Disorder Drug Market CR5 and HHI
  16. 4.8.2 2025 Gastric Motility Disorder Drug Tier 1, Tier 2, and Tier 3
5 Gastric Motility Disorder Drug Market by Type
  1. 5.1 Global Gastric Motility Disorder Drug Revenue by Type
  2. 5.1.1 Global Gastric Motility Disorder Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gastric Motility Disorder Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gastric Motility Disorder Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gastric Motility Disorder Drug Sales by Type
  6. 5.2.1 Global Gastric Motility Disorder Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gastric Motility Disorder Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Gastric Motility Disorder Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gastric Motility Disorder Drug Price by Type
6 Gastric Motility Disorder Drug Market by Application
  1. 6.1 Global Gastric Motility Disorder Drug Revenue by Application
  2. 6.1.1 Global Gastric Motility Disorder Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gastric Motility Disorder Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gastric Motility Disorder Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gastric Motility Disorder Drug Sales by Application
  6. 6.2.1 Global Gastric Motility Disorder Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gastric Motility Disorder Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Gastric Motility Disorder Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gastric Motility Disorder Drug Price by Application
7 Company Profiles
  1. 7.1 Theravance, Inc.
  2. 7.1.1 Theravance, Inc. Company Information
  3. 7.1.2 Theravance, Inc. Business Overview
  4. 7.1.3 Theravance, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Theravance, Inc. Gastric Motility Disorder Drug Product Portfolio
  6. 7.1.5 Theravance, Inc. Recent Developments
  7. 7.2 Targacept, Inc.
  8. 7.2.1 Targacept, Inc. Company Information
  9. 7.2.2 Targacept, Inc. Business Overview
  10. 7.2.3 Targacept, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Targacept, Inc. Gastric Motility Disorder Drug Product Portfolio
  12. 7.2.5 Targacept, Inc. Recent Developments
  13. 7.3 Helsinn Healthcare S.A.
  14. 7.3.1 Helsinn Healthcare S.A. Company Information
  15. 7.3.2 Helsinn Healthcare S.A. Business Overview
  16. 7.3.3 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Product Portfolio
  18. 7.3.5 Helsinn Healthcare S.A. Recent Developments
  19. 7.4 Concert Pharmaceuticals, Inc.
  20. 7.4.1 Concert Pharmaceuticals, Inc. Company Information
  21. 7.4.2 Concert Pharmaceuticals, Inc. Business Overview
  22. 7.4.3 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Product Portfolio
  24. 7.4.5 Concert Pharmaceuticals, Inc. Recent Developments
  25. 7.5 ChironWells GmbH
  26. 7.5.1 ChironWells GmbH Company Information
  27. 7.5.2 ChironWells GmbH Business Overview
  28. 7.5.3 ChironWells GmbH Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 ChironWells GmbH Gastric Motility Disorder Drug Product Portfolio
  30. 7.5.5 ChironWells GmbH Recent Developments
8 North America
  1. 8.1 North America Gastric Motility Disorder Drug Market Size by Type
  2. 8.1.1 North America Gastric Motility Disorder Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Gastric Motility Disorder Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Gastric Motility Disorder Drug Price by Type (2021-2032)
  5. 8.2 North America Gastric Motility Disorder Drug Market Size by Application
  6. 8.2.1 North America Gastric Motility Disorder Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Gastric Motility Disorder Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Gastric Motility Disorder Drug Price by Application (2021-2032)
  9. 8.3 North America Gastric Motility Disorder Drug Market Size by Country
  10. 8.3.1 North America Gastric Motility Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gastric Motility Disorder Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gastric Motility Disorder Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Gastric Motility Disorder Drug Market Size by Type
  2. 9.1.1 Europe Gastric Motility Disorder Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gastric Motility Disorder Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Gastric Motility Disorder Drug Price by Type (2021-2032)
  5. 9.2 Europe Gastric Motility Disorder Drug Market Size by Application
  6. 9.2.1 Europe Gastric Motility Disorder Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gastric Motility Disorder Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Gastric Motility Disorder Drug Price by Application (2021-2032)
  9. 9.3 Europe Gastric Motility Disorder Drug Market Size by Country
  10. 9.3.1 Europe Gastric Motility Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gastric Motility Disorder Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gastric Motility Disorder Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Gastric Motility Disorder Drug Market Size by Type
  2. 10.1.1 China Gastric Motility Disorder Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Gastric Motility Disorder Drug Sales by Type (2021-2032)
  4. 10.1.3 China Gastric Motility Disorder Drug Price by Type (2021-2032)
  5. 10.2 China Gastric Motility Disorder Drug Market Size by Application
  6. 10.2.1 China Gastric Motility Disorder Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Gastric Motility Disorder Drug Sales by Application (2021-2032)
  8. 10.2.3 China Gastric Motility Disorder Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gastric Motility Disorder Drug Market Size by Type
  2. 11.1.1 Asia Gastric Motility Disorder Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gastric Motility Disorder Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Gastric Motility Disorder Drug Price by Type (2021-2032)
  5. 11.2 Asia Gastric Motility Disorder Drug Market Size by Application
  6. 11.2.1 Asia Gastric Motility Disorder Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gastric Motility Disorder Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Gastric Motility Disorder Drug Price by Application (2021-2032)
  9. 11.3 Asia Gastric Motility Disorder Drug Market Size by Country
  10. 11.3.1 Asia Gastric Motility Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gastric Motility Disorder Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gastric Motility Disorder Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gastric Motility Disorder Drug Market Size by Type
  2. 12.1.1 SAMEA Gastric Motility Disorder Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gastric Motility Disorder Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gastric Motility Disorder Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Gastric Motility Disorder Drug Market Size by Application
  6. 12.2.1 SAMEA Gastric Motility Disorder Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gastric Motility Disorder Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gastric Motility Disorder Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Gastric Motility Disorder Drug Market Size by Country
  10. 12.3.1 SAMEA Gastric Motility Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gastric Motility Disorder Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gastric Motility Disorder Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gastric Motility Disorder Drug Value Chain Analysis
  2. 13.1.1 Gastric Motility Disorder Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gastric Motility Disorder Drug Production Mode & Process
  6. 13.2 Gastric Motility Disorder Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gastric Motility Disorder Drug Distributors
  9. 13.2.3 Gastric Motility Disorder Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst